Top Story

Clinical trial results for oral insulin show promise

October 25, 2014

Oramed Pharmaceuticals Inc. recently announced positive clinical results from its phase 2a clinical trial of ORMD-0801, oral insulin capsules, to treat type 1 diabetes, according to a press release.

The safety and effectiveness of ORMD-0801 given before meals were evaluated by a prospective, randomized, double blind, placebo-controlled trial among 25 patients with type 1 diabetes. Results indicated that oral insulin was safe and well tolerated for the dosing regimen in the study.

figure Meeting News Coverage

Efficacy, safety of aspirin for treatment of patients with diabetes, CAD unclear

October 24, 2014
BOSTON — The benefits of using aspirin, alone or with a platelet inhibitor, for the treatment of patients with diabetes at high-risk for CVD are still unclear…
figure Meeting News CoverageVideo

CMHC 2014 brings together specialists to share questions, knowledge

October 24, 2014
BOSTON — In this video, George L. Bakris, MD, FAHA, FASN, member of the executive committee for the 2014 Cardiometabolic Health Congress, highlights the benefits…
figure Health Care Legislative and Regulatory Update

Reducing the burden of Medicare's physician quality-reporting system

October 23, 2014
From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of…
CME
figure

Acromegaly Cases: Expert Insights into Diagnosis and Emerging Treatment Options – Part 5 of 5

This activity is supported by an educational grant from Genentech.

Acromegaly is a rare chronic disorder that is typically caused by excessive growth hormone secretion, and is…
More »
Meeting News Coverage Video
figure

CMHC 2014 brings together specialists to share questions, knowledge

October 24, 2014
BOSTON — In this video, George L. Bakris, MD, FAHA, FASN, member of the executive committee for the 2014…
More »
CME
figure

Treatment of Acromegaly: Current Options - Part 3 of 5

This activity is supported by an educational grant from Genentech.

The goals of treatment for patients with acromegaly include controlling growth hormone excess, and relieving signs and…
More »

Filter By:

Clinical trial results for oral insulin show promise

October 25, 2014
Oramed Pharmaceuticals Inc. recently announced positive clinical results from its phase 2a clinical trial of ORMD-0801, oral insulin capsules, to…
figure Meeting News Coverage

Efficacy, safety of aspirin for treatment of patients with diabetes, CAD unclear

October 24, 2014
BOSTON — The benefits of using aspirin, alone or with a platelet inhibitor, for the treatment of patients with diabetes at high-risk for CVD…
figure Meeting News Coverage Video

CMHC 2014 brings together specialists to share questions, knowledge

October 24, 2014
BOSTON — In this video, George L. Bakris, MD, FAHA, FASN, member of the executive committee for the 2014 Cardiometabolic Health Congress…
figure Health Care Legislative and Regulatory Update

Reducing the burden of Medicare's physician quality-reporting system

October 23, 2014
From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh…
figure Meeting News Coverage

Misinterpretation of cholesterol, risk-assessment guidelines may produce unintended consequences

October 23, 2014
BOSTON — Misinterpretation of the 2013 American College of Cardiology/American Heart Association guidelines on cholesterol management and CV…

Morale rises, but more physicians feel overextended

October 23, 2014
An increasing number of physicians reported they are overextended or at full capacity, according to results of a national survey conducted this year…
In the Journals

BPA absorbed into body through cash register receipts

October 23, 2014
High levels of the endocrine disruptor bisphenol A found in humans are likely coming from thermal paper used in cash register receipts, according to…
FDA News

FDA accepts new drug application for empagliflozin, metformin combo therapy

October 21, 2014
The FDA accepted the filing of a new drug application for empagliflozin plus immediate-release metformin hydrochloride fixed-dose combination to…
Meeting News Coverage

FDA approves remote mobile communications device for CGM

October 21, 2014
Dexcom Inc. recently announced that the FDA has granted approval for its continuous glucose monitoring remote mobile communications device, Dexcom…
Worth Building

Follow a checklist to help decide what to do with estate life insurance

October 20, 2014
Before recent changes in estate laws, it was common for attorneys, financial planners and insurance agents to recommend purchasing life insurance…
More Headlines »